Keyphrases
Chronic Myeloid Leukemia
100%
Targeted Therapeutics
100%
Pharmacogenetics and Pharmacogenomics
100%
Targeted Drugs
75%
Family Gene
50%
Improved Outcomes
25%
Signaling Pathway
25%
Cytotoxic Chemotherapy
25%
Patient Outcomes
25%
Drug Resistance
25%
Drug Response
25%
Decision Outcomes
25%
Drug Transporters
25%
Genetic Variants
25%
Treatment Decisions
25%
Clinical Response
25%
Leukemia Patients
25%
Cancer Drugs
25%
Cytochrome P450 3A (CYP3A)
25%
Inter-individual Variation
25%
Downstream Signaling
25%
Somatic Factors
25%
Germline Factor
25%
Drug Metabolism Genes
25%
SLC Family
25%
BCR-ABL1
25%
ABC Family
25%
Somatic Variation
25%
Medicine and Dentistry
Pharmacogenetics
100%
Chronic Myelogenous Leukemia
100%
Pharmacogenomics
100%
Somatics
50%
Multigene Family
50%
Malignant Neoplasm
25%
Drug Response
25%
Cytotoxic Chemotherapy
25%
CYP3A
25%
Signal Transduction
25%
Drug Resistance
25%
Drug Metabolism
25%
Germ Cell
25%
Immunology and Microbiology
Myeloid
100%
Pharmacogenetics
100%
Pharmacogenomics
100%
Multigene Family
50%
Drug Resistance
25%
Drug Response
25%
Signal Transduction
25%
Drug Metabolism
25%
Germ Cell
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenomics
100%
Pharmacogenetics
100%
Chronic Myeloid Leukemia
100%
Cytotoxic Chemotherapy
25%
Malignant Neoplasm
25%
CYP3A
25%
Drug Resistance
25%
Drug Metabolism
25%